IDEXX Laboratories, Inc.  

(Public, NASDAQ:IDXX)   Watch this stock  
Find more results for IDXX
-0.73 (-1.16%)
Jul 2 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 62.09 - 63.48
52 week 56.74 - 84.25
Open 62.96
Vol / Avg. 768,366.00/821,967.00
Mkt cap 5.84B
P/E 34.18
Div/yield     -
EPS 1.83
Shares 93.59M
Beta 0.80
Inst. own 98%
Jul 23, 2015
Q2 2015 IDEXX Laboratories Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 9, 2015
IDEXX Laboratories Inc at William Blair Annual Growth Stock Conference
May 6, 2015
IDEXX Laboratories Inc Annual Shareholders Meeting
Apr 28, 2015
Q1 2015 IDEXX Laboratories Inc Earnings Release
Apr 28, 2015
Q1 2015 IDEXX Laboratories Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 12.18% 12.25%
Operating margin 19.03% 17.52%
EBITD margin - 21.48%
Return on average assets 13.27% 13.92%
Return on average equity 246.66% 57.23%
Employees 6,400 -
CDP Score - -


1 Idexx Dr
WESTBROOK, ME 04092-2041
United States - Map
+1-207-5560300 (Phone)
+1-207-5564346 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. Its segments include Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy, and Other. Its Products and services include point-of-care veterinary diagnostic products; veterinary reference laboratory diagnostic and consulting services; practice management systems and services, and digital imaging systems; biological materials testing, laboratory animal diagnostic instruments and services; diagnostic, health-monitoring and food safety testing products for livestock, poultry and dairy; products that test water for microbiological contaminants, and point-of-care electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market.

Officers and directors

Jonathan W. Ayers Chairman of the Board, President, Chief Executive Officer
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Brian P. McKeon Chief Financial Officer, Executive Vice President, Treasurer
Age: 52
Bio & Compensation  - Reuters
Jay Mazelsky Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Johnny D. Powers Ph.D. Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Michael J. Williams Ph.D. Executive Vice President
Age: 47
Bio & Compensation  - Reuters
Jacqueline L. Studer Corporate Vice President, General Counsel, Secretary
Age: 56
Bio & Compensation  - Reuters
William T. End Lead Independent Director
Age: 67
Bio & Compensation  - Reuters
Thomas Craig Independent Director
Age: 60
Bio & Compensation  - Reuters
Rebecca M. Henderson Ph.D. Independent Director
Age: 54
Bio & Compensation  - Reuters
Barry C. Johnson Ph.D. Independent Director
Age: 71
Bio & Compensation  - Reuters